BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16417648)

  • 1. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.
    Pinzon-Charry A; Maxwell T; McGuckin MA; Schmidt C; Furnival C; López JA
    Breast Cancer Res; 2006; 8(1):R5. PubMed ID: 16417648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
    Gervais A; Levêque J; Bouet-Toussaint F; Burtin F; Lesimple T; Sulpice L; Patard JJ; Genetet N; Catros-Quemener V
    Breast Cancer Res; 2005; 7(3):R326-35. PubMed ID: 15987427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines in the generation and maturation of dendritic cells: recent advances.
    Zou GM; Tam YK
    Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
    Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
    Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.
    Yano Y; Ueda Y; Itoh T; Fuji N; Okugawa K; Naito K; Imura K; Kohara J; Hayashi T; Nakane K; Matsuura Y; Kawai K; Yamagishi H
    Oncol Rep; 2006 Jul; 16(1):147-52. PubMed ID: 16786138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-stranded RNA stimulation or CD40 ligation of monocyte-derived dendritic cells as models to study their activation and maturation process.
    Megiovanni AM; Sanchez F; Gluckman JC; Rosenzwajg M
    Eur Cytokine Netw; 2004; 15(2):126-34. PubMed ID: 15319172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity.
    Kim HJ; Kim HO; Lee K; Baek EJ; Kim HS
    Vaccine; 2010 Apr; 28(16):2877-86. PubMed ID: 20156531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
    Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
    Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation.
    Dillon SM; Rogers LM; Howe R; Hostetler LA; Buhrman J; McCarter MD; Wilson CC
    J Immunol; 2010 Jun; 184(12):6612-21. PubMed ID: 20483758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.
    Yu B; Kusmartsev S; Cheng F; Paolini M; Nefedova Y; Sotomayor E; Gabrilovich D
    Clin Cancer Res; 2003 Jan; 9(1):285-94. PubMed ID: 12538481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytofluorimetric evaluation of peripheral blood dendritic cells in patients with Mediterranean Kaposi's sarcoma].
    Vaccari M; Della Bella S; Brambilla L; Ferrucci S; Nicola S; Berti E; Boneschi V; Villa ML
    Minerva Med; 2003 Dec; 94(6):379-86. PubMed ID: 14976466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells.
    Pietra G; Mortarini R; Parmiani G; Anichini A
    Cancer Res; 2001 Nov; 61(22):8218-26. PubMed ID: 11719453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
    Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
    Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
    Kurlander RJ; Tawab A; Fan Y; Carter CS; Read EJ
    Transfusion; 2006 Sep; 46(9):1494-504. PubMed ID: 16965575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells.
    Holtick U; Marshall SR; Wang XN; Hilkens CM; Dickinson AM
    Transplantation; 2008 Mar; 85(5):757-66. PubMed ID: 18337671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.